Alice Kamp Goshorn, senior patent analyst, Bristol-Myers Squibb
Sally Gould, senior director, RA & QA, Emergent Product Development
Kenneth Grabstein, chief scientific officer, Allozyne
Leah Grant, president, Fluidea
Kris Greco Thompson, director of development and communications, The Wallace Medical Concern
Jennifer Greenough, director of global project management, Amgen
Steve Griggs, director of research informatics, Fred Hutchinson Cancer Research Center
Erwin Guadiz, PC infrastructure support team leader, Bayer Healthcare
Heidi Hagen, senior vice president of operations, Dendreon
Brian Hall, associate director of FP&A, Seattle Genetics [Updated: 1:20 pm, 1/26/11]
Patty Hall, associate director, clinical research, Emergent Product Development [Added: 12:25 pm, 1/4/11]
Roberta Hanna, bioanalytical scientist
Julia Hart, director of quality and regulatory affairs, LifeCenter Northwest
Danielle Hartigh, group brand leader, Medicis
Ann Hayes, founder, The Danica Children’s Foundation, founder, Concern for the Girl Child
Christopher Henney, chairman of the board, Oncothyreon
Aurora Henry, raw material technical expert
Bruce Hess, research associate, VLST [Added: 8:50 am, 1/4/11]
Jeff Hesselberg, vice president of regulatory affairs, GTx
Rose Hesselbrock, administrative manager, Fred Hutchinson Cancer Research Center
Tom Hopp, vice president of R&D, CG Therapeutics
Kay Humm, affiliate assistant professor of pharmacy, University of Washington
Gary Hurley, founder/principal, Creative Media Alliance
Eric Jeffery, CRA, Hematologics
Claudia Jochheim, principal consultant, Claudia Jochheim CMC Consulting
Jim Johnson, senior financial executive, former chief financial officer, ZymoGenetics
Jake Johnston, president, The Johnston Group
Andreas Kalmes, senior medical writer, Revalesio
Janet Kautz, independent accounting professional
Ajamete Kaykas, director, Allen Institute for Brain Science [Added: 9:20 pm, 1/4/11]
Mary Kennedy, medical and scientific editor, Mary Kennedy Biomedical Editing
